Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDPK1 | O15530 | 1/20 | 0.33 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.31 |
| ▸ | SRC | P12931 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19152636 | 0.93 | PDPK1 (0.33) | PDPK1DYRK1ASRC | |
| SCHEMBL17232736 | 0.79 | SRC (0.32) | SRC | |
| SCHEMBL17232763 | 0.79 | MB (0.30) | — | |
| SCHEMBL18238918 | 0.77 | PARP1 (0.31) | — | |
| SCHEMBL19152697 | 0.70 | MEN1 (0.39) | PDPK1 | |
| SCHEMBL22743476 | 0.68 | PARP1 (0.45) | — | |
| SCHEMBL19902649 | 0.68 | PARP1 (0.42) | — | |
| SCHEMBL13343468 | 0.67 | SRC (0.32) | SRC | |
| SCHEMBL19133894 | 0.67 | MET (0.33) | PDPK1DYRK1A | |
| SCHEMBL19153586 | 0.67 | MEN1 (0.39) | PDPK1DYRK1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170202970-A1 | SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME | BLINKBIO, INC. | 2017-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170202970-A1 | SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME | CD44, MSN, AS3MT | PDPK1 2826/4885DYRK1A 1107/4885SRC 378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.